Brain biochemistry in williams syndrome: Evidence for a role of the cerebellum in cognition?

Neurology

Volumn 51, Issue 1, 1998, Pages 33-40

  Rae, Caroline ^a   Karmiloff Smith, A ^b,c   Lee, M A ^d   Dixon, R M ^a   Grant, J ^b,c   Blamire, A M ^a   Thompson, C H ^a   Styles, P ^a   Radda, G K ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE DERIVATIVE; CREATINE; N ACETYLASPARTIC ACID; PHOSPHATASE;

ADOLESCENT; ADULT; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROCHEMISTRY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SCHOOL CHILD; WILLIAMS BEUREN SYNDROME;

EID: 0031817968     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.1.33     Document Type: Article

References (46)

1. Williams JC, Barratt-Boyes BG, Lowe JB. Supravalvular aortic stenosis. Circulation 1961;24:1311-1318.
2. Ewart AK, Morris CA, Atkinson D, et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet 1993;5:11-16.
3. Frangiskakis JM, Ewart AK, Morris CA, et al. LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell 1996;86:59-69.
4. Tassabehji MK, Metcalfe K, Fergusson WD, et al. LIM-Kinase-1 detected in Williams syndrome. Nat Genet 1996;13: 272-273.
5. Tassabehji MK, Karmiloff-Smith A, Grant J, et al. Genotype phenotype correlations in Williams syndrome. Am J Hum Genet 1998;61:11.
6. Pröschel C, Blouin MJ, Gutowski NJ, Ludwig R, Noble M. LimK1 is predominantly expressed in neural tissues and phosphorylates serine, threonine and tyrosine residues in vitro. Oncogene 1995;11:1271-1281.
7. Wang KK, Samos CH, Peoples R, Perez-Jurado LA, Nusse R, Francke U. A novel human homologue of the drosophila frizzled wnt receptor gene binds wingless protein and is in the Williams syndrome deletion at 7qll.23. Hum Mol Genet 1997;6:465-472.
8. Udwin O, Yule WA. Cognitive and behavioural phenotype in Williams syndrome. J Clin Exp Neuropsychol 1991;13:232-244.
9. Bellugi U, Marks S, Bihrle AM, Sabo H. Dissociation between language and cognitive functions in Williams Syndrome. In: Bishop D, Mogford K, eds. Language development in exceptional circumstances. London: Churchill Livingstone, 1988: 177-189.
10. Karmiloff-Smith A, Klima E, Bellugi U, Grant J, Baron-Cohen S. Is there a social module? Language, face processing and theory-of-mind in subjects with Williams syndrome. J Cogn Neurosci 1995;7:196-208.
11. Karmiloff-Smith A, Grant J, Berthoud I, Davies M, Howlin P, Udwin O. Language and Williams syndrome: how intact is "intact"? Child Dev 1997;68:246-262.
12. Jernigan TL, Bellugi U, Sowell E, Doherty S, Hesselink JR. Cerebral morphologic distinctions between Williams and Down syndromes. Arch Neurol 1993;50:186-191.
13. Galaburda AM, Wang PP, Bellugi U, Rossen M. Cytoarchitectonic anomalies in a genetically based disorder: Williams syndrome. Neuroreport 1994;5:753-757.
14. Neville HJ, Mills DL, Bellugi U. Effects of altered auditory sensitivity and age of language acquisition on the development of language-relevant neural systems: preliminary studies of Williams syndrome. In: S Broman, Grafman J, eds. Atypical cognitive deficits in developmental disorders: implications for brain function. Hillsdale, NJ: Lawrence Erlbaum, 1994:67-83.
15. 31P magnetic resonance spectroscopy and neuropsychological study. Lancet 1995;345: 1260-1264.
16. Gadian DG, Isaacs EB, Cross JH, et al. Lateralization of brain function in childhood revealed by magnetic resonance spectroscopy. Neurology 1996;46:974-977.
17. Rae C, Scott RB, Thompson CH, et al. Is pH a biochemical marker of IQ? Proc R Soc Lond Series B 1996;263:1061-1064.
18. 31P magnetic resonance. J Biol Chem 1973;248:7276-7278.
19. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989;11: 47-63.
20. Barker PB, Breiter SN, Soher BJ, et al. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 1994;32:157-163.
21. Deary IJ. Reductionism and the case for inspection time. J Biosoc Sci 1996;28:405-423.
22. Anderson M. Intelligence and development: A cognitive theory. Oxford: Blackwell, 1992.
23. 31P MRS of PCA extracts of postmortem Alzheimer's disease brain. Neurobiol Aging 1996;17:349-357.
24. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia. Schizophrenia Bull 1993;19:35-53.
25. Kato T, Shiori T, Murashita J, Hamakawa H, Inubushi T, Takahashi S. Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder. Psychiatry Res Neuroimaging 1994;55:41-50.
26. 31P magnetic resonance spectroscopic imaging of white matter signal hyperintensity areas in elderly subjects. Neuroradiology 1995;37:615-23.
27. 31P MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes. Biol Psychiatry 1993;33:762-773.
28. Wang PP, Hesselink JR, Jernigan TL, Doherty S, Bellugi U. The specific neurobehavioral profile of Williams syndrome is associated with neocerebellar hemispheric preservation. Neurology 1992;42:1999-2002.
29. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural types. J Neurosci 1993;13:981-989.
30. 1H MRS studies in vivo. Neuroreport 1995;7:1397-1400.
31. de Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1996;34:721-727.
32. Hashimoto T, Tayama M, Miyazaki M, et al. Reduced N-acetylaspartate in the brain observed in in vivo proton magnetic resonance spectroscopy in patients with mental retardation. Pediatr Neurol 1995;13:205-208.
33. 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 1996;58: 1929-1935.
34. Eccles J. Cerebellar function and the control of movement. In: Rose FC, ed. Physiological aspects of clinical neurology. Oxford: Blackwell, 1977:157-178.
35. Chapman CA, du Plessis A, Pober BR. Neurological findings in children and adults with Williams syndrome. J Child Neurol 1995;10:63-65.
36. Schmahmann JD. An emerging concept: the cerebellar contribution to higher function. Arch Neurol 1991;48:1178-1187.
37. Ivry RB, Keele SW, Diener HC. Dissociation of the lateral and medial cerebellum in movement timing and movement execution. Exp Brain Res 1988;73:167-180.
38. Fiez JA, Petersen SE, Cheney MK, Raichle ME. Impaired non-motor learning and error detection associated with cerebellar damage. A single case study. Brain 1992;115:155-178.
39. Bracke-Tolkmitt R, Linden A, Canavan AGM, et al. The cerebellum contributes to mental skills. Behav Neurosci 1989;103: 442-446.
40. Petersen SE, Fox PT, Posner MI, Mintun M, Raichle ME. Positron emission tomographic studies of the cortical anatomy of single-word processing. J Cogn Neurosci 1989;1:153-170.
41. van Mier H, Tempel LW, Perlmutter JS, Raichle ME, Petersen SE. Generalization of practice-related effects in motor learning using the dominant and non-dominant hand measured by PET. Soc Neurosci Abstr 1995;21:1441. Abstract.
42. Roland PE, Eriksson L, Widen L, Stone-Elander S. Changes in regional cerebral oxidative metabolism induced by tactile learning and recognition in man. Eur J Neurosci 1989;1:3-18.
43. Leiner HC, Leiner AL, Dow RS. Cerebro-cerebellar learning loops in apes and humans. Ital J Neurol Sci 1987;8:425-436.
44. Decety J, Ingvar DH. Brain structures participating in mental stimulation of motor behaviour: a neuropsychological interpretation. Acta Psychol (Amst) 1990;73:13-34.
45. Botez-Marquard T, Botez MI. Cognitive behaviour in herododegenerative ataxias. Eur Neurol 1993;33:351-357.
46. 1H magnetic resonance and neuropsychological study. J Neurol Sci 1998 (in press).